Igor Klem, MD
Cardiovascular Disease · Durham, NCNPI 1104042936
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,500 of the $13,517 with a category attached, or 92.5%. Bayer accounts for 96.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2020 at $9,101 and has fallen 98.5% since, to $138 in 2025.
Across 9 payments — averaging $1501.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$13K
- Siemens Medical Solutions USA, Inc.$253
- Bayer Healthcare LLC$96
- Canon Medical Systems USA, Inc.$68
Across 4 payments — averaging $16,544 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer Healthcare LLC$49K
- Medtronic$17K
What the payments were for
- Consulting fees$12,50092%
- Travel & lodging$6014%
- Food & beverage$4163%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 3 | $13,101 |
| Siemens Medical Solutions USA, Inc. | 4 | $253 |
| Bayer Healthcare LLC | 1 | $96 |
| Canon Medical Systems USA, Inc. | 1 | $68 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Gadavist$9,101
How this compares
$13,517 in reported general payments places this provider in the 80th percentile of 727 cardiovascular disease providers in North Carolina.
See all cardiovascular disease providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 23 | $34,753 |
| EntrestoSacubitril/Valsartan | 11 | $13,004 |
| Metoprolol Succinate | 58 | $999 |
| Amlodipine Besylate | 39 | $524 |
| Losartan Potassium | 37 | $381 |
| Amiodarone Hcl | 14 | $340 |
| Atorvastatin Calcium | 28 | $323 |
| Carvedilol | 40 | $295 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 19 | $187 |
| ClopidogrelClopidogrel Bisulfate | 13 | $162 |
| Spironolactone | 24 | $150 |
| Rosuvastatin Calcium | 22 | $142 |
| Nitroglycerin | 11 | $133 |
| Lisinopril | 26 | $106 |
| Metoprolol Tartrate | 16 | $76 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Durham
- R WilliamsDurham$2.1M
- Marat FudimDurham$902K
- Jonathan PicciniDurham$767K
- Robert MentzDurham$489K
- Adrian HernandezDurham$409K
- Neha PagidipatiDurham$301K
- Joseph KissloDurham$283K
- Mitchell KrucoffDurham$281K
- Ankeet BhattDurham$258K
- Christopher GrangerDurham$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.